Sotera Health CO Form 4 insider transactions

GTCR entities disposed of 8 million shares of Sotera Health Co. common stock in an underwritten public secondary offering at $15.111 per share.

Sotera Health's President of Sterigenics, Michael P. Rutz, reported the sale of 126,611 shares of common stock for approximately $2.07 million, effective August 22, 2025.

Sotera Health's CFO, Jonathan M. Lyons, reported the withholding of 11,508 shares of common stock to cover tax obligations related to the vesting of Restricted Stock Units.

Sotera Health Co. Director Karen Flynn was granted 19,132 restricted stock units (RSUs) on May 22, 2025, as part of the company's 2020 Omnibus Incentive Plan.

Sotera Health Co. director Robert Knauss was granted 19,132 restricted stock units as part of his compensation, aligning his interests with shareholders.

Sotera Health Company's Director, David E. Wheadon, was granted 19,132 restricted stock units (RSUs) on May 22, 2025, as part of the company's 2020 Omnibus Incentive Plan.

Sotera Health Co. Director Vincent K. Petrella was granted 19,132 restricted stock units (RSUs) on May 22, 2025, as part of his compensation, increasing his total beneficial ownership to 80,781 shares.

Sotera Health Co. Director James Neary was granted 19,132 restricted stock units (RSUs) on May 22, 2025, as part of his compensation, aligning his interests with shareholders.

Sotera Health Co. Director Constantine S. Mihas has acquired 19,132 restricted stock units (RSUs) as part of his compensation, increasing his beneficial ownership in the company.

Sotera Health Company's Director, Ann R. Klee, was granted 19,132 restricted stock units as part of her compensation, vesting over the next year.

Sotera Health Co. Director Sean Laurence Cunningham was granted 19,132 restricted stock units (RSUs) on May 22, 2025, increasing his total beneficial ownership to 80,781 shares.

Sotera Health Co. Director and 10% owner, Ruoxi Chen, was granted 19,132 restricted stock units (RSUs) on May 22, 2025, as part of the company's incentive plan.

Sotera Health Co. Director Christopher Simon was granted 19,132 restricted stock units (RSUs) on May 22, 2025, as part of the company's 2020 Omnibus Incentive Plan.

Sotera Health's CEO, Michael B. Petras Jr., reports the acquisition and disposal of company stock and derivative securities, including transactions related to tax obligations and vesting of restricted stock units and performance stock units.

Michael Rutz, President of Sterigenics at Sotera Health Co, reports acquisition and disposal of common stock and restricted stock units (RSUs) related to tax obligations and new grants.

Jonathan Lyons, CFO of Sotera Health Co, reports acquisition and disposal of common stock and restricted stock units (RSUs) on March 2nd and 3rd, 2025.

Alexander Dimitrief, SVP, General Counsel and Secretary of Sotera Health Co, reports acquisition and disposal of company stock and RSUs.

Sotera Health's CEO, Michael B. Petras Jr., reported the withholding of shares for tax obligations and the transfer of shares to a family trust.

Sotera Health's President of Sterigenics, Michael Rutz, reported a transaction involving the withholding of shares to cover tax obligations related to vested Restricted Stock Units.

Sotera Health's Chairman and CEO, Michael B. Petras Jr., reported a gift of 200,000 shares to a charitable foundation and updated his beneficial ownership in a recent SEC filing.

Warburg Pincus has sold 15,000,000 shares of Sotera Health Co (SHC) in a public secondary offering on September 6, 2024, at a price of $15.03 per share.

Warburg Pincus and affiliated entities sold 15 million shares of Sotera Health Co in a public secondary offering on September 6, 2024.

GTCR Investment XI LLC and affiliated entities sold 10 million shares of Sotera Health Co (SHC) at $15.03 per share in an underwritten public secondary offering.

Sotera Health's CFO, Jonathan Lyons, reports the withholding of shares to cover tax obligations upon the vesting of restricted stock units.

Director Karen Flynn acquired 20,089 Restricted Stock Units (RSUs) in Sotera Health Co on May 24, 2024, under the company's 2020 Omnibus Incentive Plan.

Director Robert Brown Knauss reports acquisition of restricted stock units and disposal of common stock in Sotera Health Co.

Director David E. Wheadon reports the acquisition of 20,089 Restricted Stock Units (RSUs) in Sotera Health Co on May 24, 2024.

Director Vincent K. Petrella reports acquisition of 20,089 Restricted Stock Units (RSUs) in Sotera Health Co.

Director James Neary received 20,089 Restricted Stock Units (RSUs) from Sotera Health Co on May 24, 2024, according to a Form 4 filing.

Director Constantine Mihas reports acquisition of 20,089 Restricted Stock Units (RSUs) and holdings of 61,649 shares of Sotera Health Co.